CIK: 1342826 - Address: C/O Maxcyte, Inc., 9713 Key West Avenue, Suite 400, Rockville, MD 20850
11 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg
S%ret111-30-532-64-82-24
S%wins100100100010010083

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y
11/5/24 16:25
11/1/24
MXCTMaxcyte, Inc.DEHealthBiolabCommercial Physical & BiologiErck Stanley CMDDS.d-1773.720-48-15269D
10/2/24 17:03
10/1/24
MXCTMaxcyte, Inc.DEHealthBiolabCommercial Physical & BiologiErck Stanley CMDDS.dm-1793.750-48-15269D
9/5/24 17:10
9/3/24
MXCTMaxcyte, Inc.DEHealthBiolabCommercial Physical & BiologiErck Stanley CMDDS.dm-1924.020-48-15269D
10/5/21 17:05
10/4/21
NVAXNovavax IncDEHealthBioPrdBiological Products, (No DiagErck Stanley CMDDOP,CEOS.d-7,544176.150-43-6424D
10/5/21 17:04
10/1/21
NVAXNovavax IncDEHealthBioPrdBiological Products, (No DiagErck Stanley CMDDOP,CEOS.d-8,580175.100-49-6724D
7/6/21 17:03
7/1/21
NVAXNovavax IncDEHealthBioPrdBiological Products, (No DiagErck Stanley CMDDOP,CEOS.dm-22,549214.380-105-8420D
11/18/20 18:09
11/16/20
NVAXNovavax IncDEHealthBioPrdBiological Products, (No DiagErck Stanley CMDDOP,CEOS.d-4,74390.650-52-7220D
10/1/20 17:39
9/30/20
NVAXNovavax IncDEHealthBioPrdBiological Products, (No DiagErck Stanley CMDDOP,CEOS.m-1,348110.230-12-3720D
9/30/20 21:27
9/28/20
NVAXNovavax IncDEHealthBioPrdBiological Products, (No DiagErck Stanley CMDDOP,CEOS.dm-3,201109.950-29-4733D
4/1/16 17:34
3/30/16
NVAXNovavax IncDEHealthBioPrdBiological Products, (No DiagErck Stanley CMDDOP,CEOS.dm-2,2045.1930-425-8478D14-38-20-4169-22-30-532-64-82
7/31/08 16:42
7/29/08
IOMIIomai CorpHealthDrugPharmaceutical PreparationsErck Stanley CMDDOP,CEOS.dm-9066.560-138-8525D

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact